Prevalence and correlates of infection with human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among drug users in Italy: A cross-sectional study

References

• Centro Operativo AIDS (COA). Aggiornamento dei casi di AIDS notificati in Italia al 31 dicembre 2005. Notiziario Istituto Superiore di Sanità, 2006;19 (Suppl 1). Available from: http://www.iss.it/binary/publ/cont/0394-9303_2006_I_19_06.1153308414.pdf.
   Google Scholar
• Mele, A, Tosti, ME, Spada, E, Mariano, A, Bianco, E, and SEIEVA Collaborative Group. Epidemiology of acute viral hepatitis: 20 y of surveillance through SEIEVA in Italy and a review of the literature. Rapporti ISTISAN 2006, 06/12. Available from: http://www.iss.it/publ/rapp/cont.php?id=1963&lang=1&tipo=5&anno=2006.
   Google Scholar
• Ministero della Salute. Sistema Informativo Sanitario – Dipartimento per la Prevenzione. Rilevazione attività nel settore delle tossicodipendenze, anno 2005. 2006. Available from: http://www.ministerosalute.it/imgs/C_17_pubblicazioni_542_allegato.pdf.
   Google Scholar
• EuroHIV. HIV/AIDS Surveillance in Europe 2003. 2004; 70:59–73. Available from: http://www.eurohiv.org/reports/report_70/pdf/report_eurohiv_70.pdf.
   Google Scholar
• Lindenburg CE, Krol A, Smit C, Buster M, Coutinho RA, Prins M. Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-y prospective cohort study. AIDS 2006; 20: 1771–5
   PubMed Web of Science ®Google Scholar
• Hope VD, Judd A, Hickman M, Sutton A, Stimson GV, Parry JV, Gill NO. HIV prevalence among injecting drug users in England and Wales 1990–2003: evidence for increased transmission in recent y. AIDS 2006; 19: 1207–14
   Google Scholar
• Giuliani M, Suligoi B. and the Italian Surveillance Working Group. Differences between non-national and indigenous patients with sexually transmitted infections in Italy and insight into the control of sexually transmitted infections. Sex Transm Dis 2004; 31: 79–84
   PubMedGoogle Scholar
• Zhang Y, Shan H, Trizzino J, Ruan Y, Beauchamp G, Mâsse B, et al. Demographic characteristics and risk behaviours associated with HIV-positive injecting drug users in Xinjiang, China. J Infect 2007; 54: 285–90
   PubMed Web of Science ®Google Scholar
• Estebanez PE, Russel NK, Aguilar D, Beland F, Zunzunegui MV. Women, drugs and HIV/AIDS: results of a multicentre European study. Int J Epidemiol 2000; 29: 734–43
   PubMed Web of Science ®Google Scholar
• Suligoi B, Magliocchetti N, Nicoletti G, Pezzotti P, Rezza G. Trends in HIV prevalence among drug users attending public drug-treatment centres in Italy, 1990–2000. J Med Virol 2004; 73: 1–6
   PubMedGoogle Scholar
• Rezza G, Salmaso S, Abeni D, Brancato G, Anemona A, Rovetta C, et al. and Italian/WHO Working Group. HIV prevalence and frequency of risk behaviour in injecting drug users entering treatment and out of treatment: a cross-sectional study in 5 Italian cities. J Drug Issues 1994; 24: 527–35
   Google Scholar
• March JC, Oviedo-Joekes E, Romero M. Factors associated with reported hepatitis C and HIV among injecting drug users in 10 European cities. Enferm Infecc Microbiol Clin 2007; 25: 91–7
   PubMedGoogle Scholar
• Quaglio G, Lugoboni F, Mezzelani P, Des Jarlais DC, Lechi A. Patients in long-term maintenance therapy for drug use in Italy: analysis of some parameters of social integration and serological status for infectious diseases in a cohort of 1091 patients. BMC Public Health 2006; 6: 216
   PubMedGoogle Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Annual Report 2005: the state of the drug problem in Europe. Lisbon. 2006.
   Google Scholar
• Amesty S, Ompad DC, Galea S, Fuller CM, Wu Y, Koblin B, Vlahov D. Prevalence and correlates of previous hepatitis B vaccination and infection among young drug users in New York City. J Community Health 2008; 33: 139–48
   PubMedGoogle Scholar
• Crofts N, Aitken CK. Incidence of blood-borne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990–1995. Med J Aust 1997; 167: 17–20
   PubMed Web of Science ®Google Scholar
• Campello C, Poli A, dal Molin G, Besozzi-Valentini F. Seroprevalence, viraemia and genotype distribution of hepatitis C virus: a community-based population study in northern Italy. Infection 2002; 30: 7–12
   PubMed Web of Science ®Google Scholar
• Neaigus A, Gyarmathy VA, Miller M, Fiedman SR, des Jarlais DC. Sexual and other non-injection risks for HBV and HCV seroconversions among non-injecting heroin users. J Infect Dis 2007; 195: 1052–61
   PubMedGoogle Scholar